𝔖 Bobbio Scriptorium

✦ LIBER ✦

Comparative effectiveness of adalimumab versus ustekinumab treatment for psoriasis: Clinical efficacy, safety, and cost per responder

Book ID: 116586422
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 47 KB
Volume: 62
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2009.11.480

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost per responder with adalimumab versu

Cost per responder with adalimumab versus ustekinumab treatment for moderate to severe psoriasis with suboptimal response to etanercept

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Cost per responder for biologic treatmen

Cost per responder for biologic treatment of psoriasis: Matching-adjusted comparisons of adalimumab with etanercept, infliximab, and ustekinumab

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Approved adalimumab dosing regimen assoc

Approved adalimumab dosing regimen associated with greater efficacy and lower cost per responder compared with 40 mg every other week dosing without initial 80 mg dose: Analysis of outcomes from adalimumab psoriasis clinical trial database

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 48 KB

PID1: COST-EFFECTIVENESS OF LEVOFLOXACIN

PID1: COST-EFFECTIVENESS OF LEVOFLOXACIN VERSUS CLARITHROMYCIN IN PATIENTS EVALUABLE FOR CLINICAL EFFICACY IN THE TREATMENT OF ACUTE BACTERIAL SINUSITIS

✍ L Ranee; B Dornsief 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

A randomised controlled trial of the cli

A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)

✍ Ramanan, Athimalaipet V; Dick, Andrew D; Benton, Diana; Compeyrot-Lacassagne, Sa 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 314 KB

Cerivastatin versus branded pravastatin

Cerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: A one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectiveness

✍ Ruth McPherson; Kim Hanna; Albert Agro; Anna Braeken 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 752 KB